Antenatal Platelet Response on Aspirin and Correlation With Hypertensive Disorders of Pregnancy: a Pharmacokinetic Study Through Pregnancy
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Preeclampsia
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: One arm PK/PD study of aspirin in pregnancy1Masking: None (Open Label)Primary Purpose: Other
Participation Requirements
- Age
- Between 13 years and 55 years
- Gender
- Only males
Description
This will be a longitudinal addition to an existing R21cohort enrolled in the first trimester to include a first and third trimester assessment of pharmacokinetics/pharmacodynamics (PK/PD) of aspirin and how individual factors impact aspirin PK/PD in pregnancy.
This will be a longitudinal addition to an existing R21cohort enrolled in the first trimester to include a first and third trimester assessment of pharmacokinetics/pharmacodynamics (PK/PD) of aspirin and how individual factors impact aspirin PK/PD in pregnancy.
Tracking Information
- NCT #
- NCT04645004
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- March of Dimes
- Investigators
- Not Provided
Get Well Soon